Literature DB >> 18725421

Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxins.

Katherine Poirier1, Sébastien P Faucher, Maxime Béland, Roland Brousseau, Victor Gannon, Christine Martin, Josée Harel, France Daigle.   

Abstract

Escherichia coli O157:H7 is an important food-borne pathogen that specifically binds to the follicle-associated epithelium in the intestine, which rapidly brings this bacterial pathogen in contact with underlying human macrophages. Very little information is available about the interaction between E. coli O157:H7 and human macrophages. We evaluated the uptake and survival of strain EDL933 during infection of human macrophages. Surprisingly, EDL933 survived and multiplied in human macrophages at 24 h postinfection. The global gene expression profile of this pathogen during macrophage infection was determined. Inside human macrophages, upregulation of E. coli O157:H7 genes carried on O islands (such as pagC, the genes for both of the Shiga toxins, and the two iron transport system operons fit and chu) was observed. Genes involved in acid resistance and in the SOS response were upregulated. However, genes of the locus of enterocyte effacement or genes involved in peroxide resistance were not differentially expressed. Many genes with putative or unknown functions were upregulated inside human macrophages and may be newly discovered virulence factors. As the Shiga toxin genes were upregulated in macrophages, survival and cytotoxicity assays were performed with isogenic Shiga toxin mutants. The initial uptake of Shiga toxins mutants was higher than that of the wild type; however, the survival rates were significantly lower at 24 h postinfection. Thus, Shiga toxins are implicated in the interaction between E. coli O157:H7 and human macrophages. Understanding the molecular mechanisms used by E. coli to survive within macrophages may help in the identification of targets for new therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725421      PMCID: PMC2573336          DOI: 10.1128/IAI.00446-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

Review 1.  Benefits and pitfalls of using microarrays to monitor bacterial gene expression during infection.

Authors:  Jay C D Hinton; Isabelle Hautefort; Sofia Eriksson; Arthur Thompson; Mikael Rhen
Journal:  Curr Opin Microbiol       Date:  2004-06       Impact factor: 7.934

2.  Two novel virulence loci, mxiA and mxiB, in Shigella flexneri 2a facilitate excretion of invasion plasmid antigens.

Authors:  G P Andrews; A E Hromockyj; C Coker; A T Maurelli
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  A random-PCR method (rPCR) to construct whole cDNA library from low amounts of RNA.

Authors:  P Froussard
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

4.  Engagement of the pathogen survival response used by group A Streptococcus to avert destruction by innate host defense.

Authors:  Jovanka M Voyich; Kevin R Braughton; Daniel E Sturdevant; Cuong Vuong; Scott D Kobayashi; Stephen F Porcella; Michael Otto; James M Musser; Frank R DeLeo
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

5.  Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.

Authors:  N C van de Kar; L A Monnens; M A Karmali; V W van Hinsbergh
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

7.  Attaching and effacing adherence of Vero cytotoxin-producing Escherichia coli to rabbit intestinal epithelium in vivo.

Authors:  P Sherman; R Soni; M Karmali
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

8.  Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture.

Authors:  Stephanie Schüller; Gad Frankel; Alan D Phillips
Journal:  Cell Microbiol       Date:  2004-03       Impact factor: 3.715

9.  An unusual pagC::TnphoA mutation leads to an invasion- and virulence-defective phenotype in Salmonellae.

Authors:  V L Miller; K B Beer; W P Loomis; J A Olson; S I Miller
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

10.  Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines.

Authors:  H W Moon; S C Whipp; R A Argenzio; M M Levine; R A Giannella
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more
  27 in total

1.  Verotoxin 2 enhances adherence of enterohemorrhagic Escherichia coli O157:H7 to intestinal epithelial cells and expression of {beta}1-integrin by IPEC-J2 cells.

Authors:  Bianfang Liu; Xianhua Yin; Yanni Feng; James R Chambers; Aiguang Guo; Joshua Gong; Jing Zhu; Carlton L Gyles
Journal:  Appl Environ Microbiol       Date:  2010-05-07       Impact factor: 4.792

2.  Differences in virulence gene expression between atypical enteropathogenic Escherichia coli strains isolated from diarrheic and healthy ruminants.

Authors:  Pilar Horcajo; Gustavo Domínguez-Bernal; Javier Carrión; Ricardo De La Fuente; José A Ruiz-Santa-Quiteria; José A Orden
Journal:  Can J Vet Res       Date:  2013-04       Impact factor: 1.310

3.  17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli.

Authors:  Christine D Palmer; Christy J Mancuso; Jerrold P Weiss; Charles N Serhan; Eva C Guinan; Ofer Levy
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

4.  Human intestinal epithelial cell-derived molecule(s) increase enterohemorrhagic Escherichia coli virulence.

Authors:  Tarun Bansal; Dae N Kim; Tim Slininger; Thomas K Wood; Arul Jayaraman
Journal:  FEMS Immunol Med Microbiol       Date:  2012-12

5.  Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines.

Authors:  Shifeng Wang; Yuhua Li; Huoying Shi; Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

6.  Subtilase cytotoxin enhances Escherichia coli survival in macrophages by suppression of nitric oxide production through the inhibition of NF-κB activation.

Authors:  Hiroyasu Tsutsuki; Kinnosuke Yahiro; Kotaro Suzuki; Akira Suto; Kohei Ogura; Sayaka Nagasawa; Hideshi Ihara; Takeshi Shimizu; Hiroshi Nakajima; Joel Moss; Masatoshi Noda
Journal:  Infect Immun       Date:  2012-09-04       Impact factor: 3.441

7.  Enterohemorrhagic Escherichia coli specific enterohemolysin induced IL-1β in human macrophages and EHEC-induced IL-1β required activation of NLRP3 inflammasome.

Authors:  Xiaoai Zhang; Yuli Cheng; Yanwen Xiong; Changyun Ye; Han Zheng; Hui Sun; Hongqing Zhao; Zhihong Ren; Jianguo Xu
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

8.  Entry and killing of Tetrahymena thermophila by bacterially produced Shiga toxin.

Authors:  Gino Stolfa; Gerald B Koudelka
Journal:  MBio       Date:  2012-12-26       Impact factor: 7.867

9.  Functional capacity of Shiga-toxin promoter sequences in eukaryotic cells.

Authors:  Leticia V Bentancor; Marcos F Bilen; María P Mejías; Romina J Fernández-Brando; Cecilia A Panek; Maria V Ramos; Gabriela C Fernández; Martín Isturiz; Pablo D Ghiringhelli; Marina S Palermo
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

10.  Proteomic View of Interactions of Shiga Toxin-Producing Escherichia coli with the Intestinal Environment in Gnotobiotic Piglets.

Authors:  Rembert Pieper; Quanshun Zhang; David J Clark; Prashanth P Parmar; Hamid Alami; Moo-Jin Suh; Srilatha Kuntumalla; John C Braisted; Shih-Ting Huang; Saul Tzipori
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.